| Date Published: | 06/18/2021 |
| Publication Name: | The Exspose' |
| Original Post (Source): | Link to Source |
| Description: | A confidentiality agreement shows potential coronavirus vaccine candidates were transferred from Moderna to the University of North Carolina in 2019, nineteen days prior to the emergence of the alleged Covid-19 causing virus in Wuhan, China. |
| Archive Link | PDF link |
Article Intro Text:
Notes:
Video:
The confidentially agreement which can be viewed here states that providers ‘Moderna’ alongside the ‘National Institute of Allergy and Infectious Diseases’ (NIAID) agreed to tranfer ‘mRNA coronavirus vaccine candidates’ developed and jointly-owned by NIAID and Moderna to recipients ‘The Universisty of North Carolina at Chapel Hill’ on the 12th December 2019.
v
The material transfer agreement was signed the December 12th 2019 by Ralph Baric, PhD, at the University of North Carolina at Chapel Hill, and then signed by Jacqueline Quay, Director of Licensing and Innovation Support at the University of North Carolina on December 16th 2019.
The agreement was also signed by two representatives of the NIAID, one of whom was Amy F. Petrik PhD, a technology transfer specialist who signed the agreement on December 12th 2019 at 8:05 am. The other signatory was Barney Graham MD PhD, an investigator for the NIAID, however this signature was not dated.
The final signatories on the agreement were Sunny Himansu, Moderna’s Investigator, and Shaun Ryan, Moderna’s Deputy General Councel. Both signautres were made on December 17th 2019.
All of these signatures were made prior to any knowledge of the alleged emergence of the novel coronavirus. It wasn’t until December 31st 2019 that the World Health Organisation (WHO) became aware of an alleged cluster of viral pneumonia cases in Wuhan, China. But even at this point they had not determined that an alleged new coronavirus was to blame, instead stating the pneumonia was of “unknown cause”.
It was not until January 9th 2020 that the WHO reported Chinese authorities had determined the outbreak was due to a novel coronavirus which later became known as SARS-CoV-2 with the alleged resultant disease dubbed COVID-19. So why was an mRNA coronavirus vaccine candidate developed by Moderna being transferred to the University of North Carolina on December 12th 2019?
The same Moderna that have had an mRNA coronavirus vaccine authorised for emergency use only in both the United Kingdom and United States to allegedly combat Covid-19.
What did Moderna know that we didn’t? In 2019 there was not any singular coronavirus posing a threat to humanity which would warrant a vaccine, and evidence suggests there hasn’t been a singular coronavirus posing a threat to humanity throughout 2020 and 2021 either.